Phoneutria nigriventer ω-Phonetoxin IIA: A new tool for anti-calcium channel autoantibody assays in Lambert–Eaton myasthenic syndrome

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurobiology of Disease

• Publication date

  2006-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nbd.2005.10.003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrophysiological diagnostic criteria of Lambert–Eaton myasthenic syndrome

  2005cited by this paper
• Dosage et spécificité d’autoanticorps anti-canaux calcium dans le syndrome myasthénique de Lambert-Eaton

  2004cited by this paper
• LEMS IgG Binds to Extracellular Determinants on N‐Type Voltage‐Gated Calcium Channels, but Does Not Reduce VGCC Expression

  2003cited by this paper
• The action of Lambert–Eaton myasthenic syndrome immunoglobulin G on cloned human voltage‐gated calcium channels

  2002cited by this paper
• Phoneutria nigriventer ω-Phonetoxin IIA Blocks the Cav2 Family of Calcium Channels and Interacts with ω-Conotoxin-binding Sites*

  2002cited by this paper
• Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line.

  2001cited by this paper
• Autonomic dysfunction in Lambert-Eaton myasthenic syndrome

  2001cited by this paper
• Structure and regulation of voltage-gated Ca2+ channels.

  2000cited by this paper
• Binding of Ala‐scanning analogs of ω‐conotoxin MVIIC to N‐ and P/Q‐type calcium channels

  2000cited by this paper
• Nomenclature of voltage-gated calcium channels.

  2000cited by this paper
• Nomenclature of voltage-gated sodium channels.

  2000cited by this paper
• Specificity of ω-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome

  1999cited by this paper
• Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

  1997cited by this paper
• Direct interaction of the calcium sensor protein synaptotagmin I with a cytoplasmic domain of the α1A subunit of the P/Q‐type calcium channel

  1997cited by this paper
• Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum

  1996cited by this paper
• Properties of ω conotoxin MVIIC receptors associated with α1A calcium channel subunits in rat brain

  1995cited by this paper
• Inhibition of calcium currents and exocytosis by Lambert‐Eaton syndrome antibodies in human lung cancer cells.

  1995cited by this paper
• Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis.

  1994cited by this paper
• CALCIUM CHANNEL DIVERSITY AND NEUROTRANSMITTER RELEASE : THE OMEGA -CONOTOXINS AND OMEGA -AGATOXINS

  1994cited by this paper
• Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.

  1993cited by this paper
• Expression of synaptotagmin and syntaxin associated with N‐type calcium channels in small cell lung cancer

  1993cited by this paper
• Primary structure and functional expression from complementary DNA of a brain calcium channel

  1991cited by this paper
• Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

  1991cited by this paper
• Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.

  1989cited by this paper
• The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

  1988cited by this paper
• The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.

  1987cited by this paper
• Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

  1985cited by this paper
• Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome

  1984cited by this paper
• Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

  1983cited by this paper
• Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

  1983cited by this paper

• Autoanticorps dans la myasthénie auto-immune et autoanticorps anti-récepteurs cholinergiques

  2021cites this paper
• Gene sequence analysis of toxins from the spider Phoneutria nigriventer revealed an intronless feature

  2020cites this paper
• Transcriptome analysis of the spider Phoneutria pertyi venom glands reveals novel venom components for the genus Phoneutria

  2019cites this paper
• An overview of Phoneutria nigriventer spider venom using combined transcriptomic and proteomic approaches

  2018cites this paper
• Chapter 74 – Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)

  2014cites this paper
• Autoanticorps antirécepteurs cholinergiques

  2012cites this paper
• A case of Lambert-Eaton myasthenic syndrome with possible myasthenia gravis.

  2012cites this paper
• Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.

  2011cites this paper
• Chapter 38 – Spider and Wasp Neurotoxins

  2009cites this paper
• Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.

  2008cites this paper
• Lambert-Eaton Myasthenic Syndrome

  2008cites this paper
• 3. Damages of Neuromuscular Junctions

  2008cites this paper
• Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)

  2007cites this paper
• Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs.

  2007cites this paper
• Paraneoplastic syndromes in neuro-ophthalmology

  2007cites this paper
• Myasthenia gravis and Lambert–Eaton myasthenic syndrome in the same patient

  2007cites this paper